Month: August 2020

The coronavirus pandemic has changed the fabric of our lives the world over. Many have lost their jobs and their livelihoods. Frankly, it’s a dark time. On the bright side, we’re learning more about the coronavirus every day, and the promise of a vaccine brings us hope. An end to our quarantined lives.   Many
0 Comments
The US Food and Drug Administration (FDA) has approved viltolarsen (Viltepso, NS Pharma), the second drug therapy for Duchenne muscular dystrophy in patients with a confirmed mutation amenable to exon 53 skipping. The FDA approved golodirsen (Vyondys 53, Sarepta Therapeutics) for this indication last year, as reported by Medscape Medical News.   “The FDA is
0 Comments
This content originally appeared on diaTribe. Republished with permission. By Eliza Skoler As COVID restrictions and recommendations shift, what do we know about staying safe with diabetes? How can we protect others and make careful decisions about risk? As the pandemic continues to unfold, states and countries are leading their own initiatives to reduce infection
0 Comments
Print this page London, 6 August 2020 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Dovato (dolutegravir/lamivudine) as a complete regimen for the treatment of HIV-1 infection to replace the current antiretroviral (ARV)
0 Comments
A police officer patrols a deserted Red Square during the pandemic of the novel coronavirus (COVID-19). Valery Sharifulin Russia has rejected international criticism and skepticism toward its coronavirus vaccine, saying that it’s safe and that it works. Russia announced Tuesday that its vaccine had been approved by its health regulators, making it the first coronavirus
0 Comments
A team of researchers at Children’s Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) further bridged the gap between genomic information and clinical outcome data by systematically linking genetic information with electronic medical records, focusing on how genetic neurological disorders in children develop over time. The findings were published today in
0 Comments
President Trump announced the deal during a media briefing on Tuesday. Moderna is one of several companies manufacturing the vaccine “at risk,” as the industry calls it, meaning the company is currently making the vaccine before it is approved. Clinical trials are currently underway to test whether it’s safe and effective. Under this contract, worth
0 Comments
Meningitis is an illness that can be very scary. It’s an infection that can make people very, very sick. Babies who get the disease are at particular risk of getting dangerously ill because it can be tricky to diagnose and symptoms can escalate quickly. More on how to recognize and treat meningitis from Mayo Clinic.
0 Comments
Following the success of their inaugural wellbeing festival in May, the Live Life Well Virtual Weekender returns from 11-13 September Over 30 expert speakers, campaigners and professionals will come together for the Live Life Well Virtual Weekender 2.0 this September, and Happiful are delighted to share that we’ll be supporting this amazing initiative once again,
0 Comments
Cannabidiol (CBD), the chemical found in the Cannabis sativa L plant, seems to be one of the most popular natural remedies on the market right now. Manufacturers are delivering CBD products in many ways, from capsules to lotions and rub-on balms, and a wide variety of edible products. One of the most trusted and dependable
0 Comments
Patients with untreated mesothelioma may be able to avoid chemotherapy, say researchers reporting new survival data with the immunotherapy combination of nivolumab (Opdivo) and ipilimumab (Yervoy). The two approaches were compared in more than 600 patients with treatment-naive mesothelioma in the phase 3 CheckMate 743 trial, which was supported by the manufacturer of both immunotherapies,
0 Comments
Print this page SOUTH SAN FRANCISCO, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) – Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its COVID-19 Investigational New Drug (IND) application has been filed with the US Food and Drug Administration (FDA). “We are very excited to reach this
0 Comments
remdesivir Treatment for COVID-19 Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury (remdesivir) for the Treatment of COVID-19 Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)–Aug. 10, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration
0 Comments
FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain Print this page CHESTERBROOK, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that the U.S. Food and Drug
0 Comments